Read

November/December 2000 Featured Stories
What Are They Doing to Our Milk?

by Robert Cohn

An epidemic rise in one under-publicized category of cancers should sound an alarm for all Americans.  There is a worrying coincidence associated with the dramatic surge in lymphatic cancer: Before 1995, lymphatic cancers were comparatively rare. In 1994 genetically engineered bovine growth hormone (rbGH) was approved for use by the FDA.  Today, if one adds up the total number of cancer deaths from breast, prostate, lung, pancreatic, and genital cancers, they do not cumulatively equal the number of deaths from lymphatic cancers.  Do I have your attention?

This year Americans will consume nearly 180 billion pounds of milk and dairy products in various forms.  That will average out to 666 pounds per American, nearly 40% of the average American diet. Cheese eaters, ice cream slurpers, and milk drinkers of both sexes and every age group will be ingesting dairy products from hormonally-treated cows.  Most Americans are unaware that laboratory animals treated with rbGH experienced enormous changes in their lymphatic systems.  The spleens of these animals grew dramatically. 

The controversial genetically modified cow hormone was approved for human consumption in February of 1994.  Cancer statistics have recently been published by the U.S. Census Bureau comparing death rates from cancer by sex and age groups in 1980, 1990, and 1995.  These data support evidence of a runaway plague. All of America became a laboratory study for rbGH, which is now in America's ice cream, cheese, and pizza.

There are small increases and decreases in lymphatic cancer rates from 1980 to 1990, depending upon sex and age group.  What happened in 1995 represents the most dramatic short-term increase of any single cancer in the history of epidemiological discovery and analyses.  

The approval process for rbGH was the most controversial drug application in the history of the Food & Drug Administration (FDA).  In order to address that controversy, the FDA published an article in the journal SCIENCE (August 24, 1990).

Data in that paper reveal that the average male rat receiving rbGH developed a spleen 39.6 percent larger than the spleen of the control animals after just 90 days of treatment.  The spleens from rbGH-treated females increased in size by a factor of 46 percent. These are not normal reactions and portray animals in distress.  These animals were "under attack" by the genetically engineered hormone.  The spleen is the first line of defense in a mammal's lymphatic system.

Lab animals treated with rbGH developed lymphatic abnormalities.  This same hormone causing changes in lab animals was introduced into America's food supply in 1994. As Americans continue to ingest genetically engineered milk and dairy products, lymphatic cancer rates soar.  Americans have become laboratory subjects in genetic engineering's experiment, and the resulting data indicate extreme cause for concern.

Robert Cohen is the Executive Director of the Dairy Education Board. For more information visit their website - http://www.notmilk.com.